NEUROMUSCULAR

NeurologyLive's Neuromuscular Clinical Focus page focuses on the latest news and research for rare disorders like amyotrophic lateral sclerosis (ALS), Duchenne muscular dystrophy (DMD), and myasthenia gravis (MG).

Comment from Daniel Barber, MBA

Riluzole Oral Film FDA-Approved for Amyotrophic Lateral Sclerosis

The approval is supported by several studies which demonstrated the drug’s bioequivalence to Rilutek, the liquid riluzole formulation marketed by Sanofi.

Risdiplam Shows Positive Results in SMA, Study Trials for DMD Discontinued, Neflamapimod Granted Fast Track for Treatment of Dementia with Lewy Bodies

Neurology News Network for the week ending November 16, 2019.

Phase 2 Data Suggests Safety of NurOwn Treatment in ALS

The mesenchymal stem cell-neurotrophic factor cells met the primary safety end point and displayed early but promising signs of efficacy, prompting excitement among investigators for moving forward with phase 3 study.

Duchenne Muscular Dystrophy Gene Therapy On Hold After Safety Incident

This is the third safety incident in the IGNITE DMD clinical trial that has resulted in a clinical hold since its inception in 2017.

Risdiplam Meets Primary Endpoint in SMA Type 2, 3

Patients with spinal muscular atrophy types 2 or 3 saw improvements in motor function after receiving risdiplam; data will be presented at an upcoming medical congress.

Diroximel Fumarate Approved for MS; Personalized Interventions Improve Cognition; Zolgensma Trial Placed on Partial Hold

Trevor Dyson-Hudson, MD: Unseen Consequences of Spinal Cord Injury

Trevor Dyson-Hudson, MD: Spinal Cord Injury Model Systems

Previous Page Next Page

About NeurologyLive's Neuromuscular Clinical Focus page:

The NeurologyLive Neuromuscular Clinical Focus page provides the latest clinical updates about neuromuscular diseases, with articles and videos covering the most up-to-date advancements in the field. Visitors to the clinical focus page will find information on emerging treatment options, as well as updates from the world’s top neurology conferences and annual meetings, including key coverage on rare disorders like ALS, DMD, and MD.

Additionally, articles and video editorial from neurologists and professionals specializing in neuromuscular conditions can be found on this page, offering expert guidance on current management strategies and potential neuromuscular therapy options.